Next to targeting DHFR, the one-carbon cycle is inhibited by drugs directed at thymidylate synthase (TYMS), like 5-fluorouracil (5-FU), which is used as first-line therapy for colorectal cancer (CRC) (Stine et al, 2022). The gene discussed is TYMS; the disease is colorectal cancer.